Tiago Pina Cabral: Can Port Maintenance be Safely Extended to 24 Weeks After Treatment Completion?
Tiago Pina Cabral, Medical Oncology Resident at Western Lisbon Local Health Unit, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“New publication – PORT-24 study
Proud to share our latest work․
We explored a simple but clinically relevant question:
- Can port maintenance be safely extended to 24 weeks after treatment completion?
What we found:
- Very low complication rate (2.33/100 port-years)
- No infections over 250 port-years
- Outcomes comparable to standard 4–12 week protocols
Take-home message:
- In selected cancer survivors, less frequent maintenance may be safe, with clear benefits for patients and healthcare systems.
But let’s be clear:
- If a port is no longer needed, it should be removed.
- Extended intervals are not a substitute for appropriate device removal, they are an option when retention is clinically justified.
Less is more… but only in the right patient.”
Title: Extended maintenance intervals for implanted venous ports in oncology: A retrospective assessment of 24-week intervals (PORT-24 study)
Authors: Tiago Pina-Cabral, Cláudia Ricou, Maria Teresa Recio, Carina Nascimento, Carla Cabral, Raquel Ferreira, Francisca Ferraz de Liz, Sandra Ponte
Read the Full Article on The Journal of Vascular Access

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis